Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53,888,889
-
Total 13F shares
-
36,462,633
-
Share change
-
+251,824
-
Total reported value
-
$502,118,395
-
Price per share
-
$13.77
-
Number of holders
-
59
-
Value change
-
+$3,284,853
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) as of Q3 2023
As of 30 Sep 2023 Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,462,633 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Boxer Capital, LLC, Canaan Partners XI LLC, FMR LLC, BVF INC/IL, Nextech Invest Ltd., TCG Crossover Management, LLC, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., and BlackRock Inc..
This table shows 59 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.